MediPharm inks deal to sell Ontario cannabis operation for $5.5 million
Canadian cannabinoid company MediPharm Labs is selling its manufacturing operation in Ontario for $5.5 million to Kensana Health.
News December 17Canadian cannabinoid company MediPharm Labs is selling its manufacturing operation in Ontario for $5.5 million to Kensana Health.
News December 17MediPharm Labs Corp.’s facility in Barrie, Ontario, received Good Manufacturing Practice (GMP) certification from Brazil's National Sanitary Surveillance…
News February 8